Pathology: metastatic/advanced OC (mOC) - maintenance (M); ovarian cancer (OC);
| metastatic/advanced OC (mOC) - maintenance (M) | ovarian cancer (OC) | |||||||||
| ATHENA-COMBO (GOG-3020/ENGOT-ov45), 2021 | ENGOT-OV16/NOVA, 2017 | PAOLA-1/ENGOT-ov25, 2019 | SOLO 1, 2018 | SOLO2/ENGOT-Ov21, 2018 | SOLO 3, 2020 | Ledermann, 2012 | ARIEL3, 2017 | ARIEL4, 2022 | ||
| olaparib | 5 | T1 | T1 | T1 | T1 | T1 | ||||
| rucaparib | 3 | T1T0 | T1 | T1 | ||||||
| niraparib | 1 | T1 | ||||||||
| Standard of Care (SoC) | 0 | T0 | T0 | T0 | T0 | T0 | T0 | T0 | T0 | |